Literature DB >> 28386817

Review of cardiovascular imaging in the journal of nuclear cardiology in 2016: Part 2 of 2-myocardial perfusion imaging.

Fadi G Hage1,2, Wael A AlJaroudi3.   

Abstract

In 2016, the Journal of Nuclear Cardiology published many high-quality articles. Similar to previous years, we will summarize here a selection of the articles that were published in the Journal in 2016 to provide a concise review of the main advancements that have recently occurred in the field. In the first article of this two-part series we focused on publications dealing with positron emission tomography, computed tomography, and magnetic resonance. This review will place emphasis on myocardial perfusion imaging using single-photon emission-computed tomography summarizing advances in the field including in diagnosis, prognosis, and appropriate use.

Keywords:  Myocardial perfusion imaging; SPECT; appropriateness; dyssynchrony; phase analysis; regadenoson; safety

Mesh:

Year:  2017        PMID: 28386817     DOI: 10.1007/s12350-017-0875-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  53 in total

Review 1.  Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?

Authors:  Leslee J Shaw; Fadi G Hage; Daniel S Berman; Rory Hachamovitch; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

2.  The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease.

Authors:  Fadi G Hage; Phillip Dean; Vikas Bhatia; Fahad Iqbal; Jaekyeong Heo; Ami E Iskandrian
Journal:  Am Heart J       Date:  2011-07-18       Impact factor: 4.749

3.  Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms.

Authors:  Rohit Bhatheja; Gary S Francis; Claire E Pothier; Michael S Lauer
Journal:  Am J Cardiol       Date:  2005-05-15       Impact factor: 2.778

4.  Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome.

Authors:  Fadi G Hage; Gilbert Perry; Jaekyeong Heo; Ami E Iskandrian
Journal:  Am J Cardiol       Date:  2010-03-15       Impact factor: 2.778

5.  Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing.

Authors:  J S Katz; M Ruisi; K N Giedd; M Rachko
Journal:  J Nucl Cardiol       Date:  2012-04-24       Impact factor: 5.952

6.  Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging.

Authors:  Shishir Mathur; Anuj R Shah; Alan W Ahlberg; Deborah M Katten; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2010-05-19       Impact factor: 5.952

7.  A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.

Authors:  Fadi G Hage; Phillip Dean; Fahad Iqbal; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2011-07-22       Impact factor: 5.952

8.  Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study.

Authors:  Aiden Abidov; Rory Hachamovitch; Sean W Hayes; Chee Keong Ng; Ishac Cohen; John D Friedman; Guido Germano; Daniel S Berman
Journal:  Circulation       Date:  2003-06-09       Impact factor: 29.690

9.  Relation between heart rate response to adenosine and mortality in patients with end-stage renal disease.

Authors:  Rajesh Venkataraman; Fadi G Hage; Todd A Dorfman; Jaekyeong Heo; Raed A Aqel; Angelo M de Mattos; Ami E Iskandrian
Journal:  Am J Cardiol       Date:  2009-03-04       Impact factor: 2.778

10.  Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.

Authors:  Fahad M Iqbal; Wael Al Jaroudi; Kumar Sanam; Aaron Sweeney; Jaekyeong Heo; Ami E Iskandrian; Fadi G Hage
Journal:  Am J Cardiol       Date:  2012-10-27       Impact factor: 2.778

View more
  6 in total

1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2018. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2019-01-02       Impact factor: 5.952

Review 2.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

Review 3.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

4.  Cases from a Busy Nuclear Cardiology Laboratory.

Authors:  Usman A Hasnie; James Barrios; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2020-08-03       Impact factor: 5.952

Review 5.  Stable Isotopes for Tracing Cardiac Metabolism in Diseases.

Authors:  Anja Karlstaedt
Journal:  Front Cardiovasc Med       Date:  2021-11-11

Review 6.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2021-06-08       Impact factor: 5.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.